Course Evaluation Survey - Atopic Dermatitis: Targeting Underlying Inflammatory Pathways with Systemic Therapy THE THRIVE INITIATIVE

What is your specialty focus?(Required)

Dermatology

Immunology/allergology

Primary care

Internal medicine

Pharmacy

Other

Specify:(Required)

What is your type of practice?(Required)

Community/Private

SNF/Nursing Home

Academic

Hospital

HMO/MCO

Other

Specify:(Required)

How many years have you been in practice?(Required)

Fewer than 5

5 to 9

10 to 15

More than 15

Please estimate the number of patients with moderate-to-severe atopic dermatitis you provide for weekly:(Required)

Were the following learning objectives met? (Please check appropriate rating)(Required)

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Apply up-to-date guidance on the initiation and use of systemic immunosuppressants and immunomodulators in patients with atopic dermatitis during the COVID-19 pandemic
Assess the severity of atopic dermatitis and select appropriate treatment options for patients who require intensified therapy
Review the mechanism of action, efficacy and safety of systemic treatments for atopic dermatitis in pediatric and adult patients

Please rate your confidence in ability to diagnose, treat, and manage moderate-to-severe atopic dermatitis on a scale of 1 to 5, where 1 means “Not confident at all” and 5 means “Very Confident.”(Required)

As a result of this course, I will likely make changes to my practice:(Required)

YES

N/A

If YES, in which of the following categories? (Please check all that apply)

Diagnosis

Treatment approach

Patient safety

Coordination of care

Patient communication/ education

In particular, as a result of this course, I will be more likely to implement the following changes (Please check all that apply):(Required)

I am more likely to assess the mental and social impact of AD when selecting treatment options.

I am more likely to identify patients with AD who require intensified therapy.

I am more likely to incorporate treatment guidelines and clinical trial data into treatment plans for adult and pediatric patients with moderate-to-severe disease.

I am more likely to consider a patient’s risk of severe COVID-19 when initiating systemic therapy.

Additionally, I will change:

Specify:

What barriers may prevent/inhibit changes in practice recommended in this activity?

Cost

Time

Number of Patients

Access/availability

Patient understanding

Compliance

Other

Specify:

Did you view the animations offered in this program?(Required)

YES

If YES, how do you feel the animations impacted your learning? (Please check all that apply)

Improved ability to assess the severity of atopic dermatitis and intensify therapy appropriately

Improved ability to select treatment options for adult and pediatric patients based on an understanding of the efficacy and safety of systemic treatments

Improved ability to apply up-to-date guidance on the initiation and use of systemic immunosuppressants and immunomodulators in patients with AD during the COVID-19 pandemic

Will improve recall of lessons learned

Will improve dialogue with patients

Will improve ability to individualize treatment

Please evaluate this activity as a whole. (Please check appropriate rating)(Required)

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
The learning format was interactive and engaging.
The content was pertinent to my professional needs.
The activity will ultimately benefit patient care.
I would recommend this activity to colleagues.

Do you feel a commercial product, device, or services was inappropriately promoted in this educational activity?(Required)

YES

If YES, please comment:(Required)

What was the most effective aspect(s) of this learning activity?(Required)

Faculty expertise

Educational format

Visual aids

Content

Case studies

Other:

Specify:(Required)

Do you have suggestions for improving the session or topics for future activities?

New and emerging therapies

Diagnostic tools/techniques

Patient education/communication

Other treatment modalities

Coordination of care

Other:

Specify:(Required)

Please evaluate the faculty (Please check appropriate rating)(Required)

Thank you. Any additional comments are welcome below.

If you have any concerns you would like to discuss, please email us at info@medlearninggroup.com. To better understand the value of this program, MLG may contact you with a follow-up survey. This survey is designed to assess the value of the program and measure any behavior change. We truly appreciate your participation.

	Excellent	Good	Average	Fair	Poor
Donald Leung, MD
Peter Lio, MD